Nicholas Naclerio

Nicholas Naclerio has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Illumina, Inc. and Alamar Biosciences, Inc. We count 165 filings; the first trade dates from 31 January 2012 and the latest from 20 April 2026.

On the open market, the record shows 1 purchase worth €3.4M and 101 sales worth €31.2M. Sales outweigh purchases by €27.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 27 share grants and 30 option exercises. In 2026 alone, the filings show 1 purchase and no sales.

Most recently, on 20 April 2026, the filings show an open-market purchase worth €3.4M in Alamar Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.